Pharmaservices - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 22,105 | 35,658 | 25,950 | 55,918 | 146,612 | 486,832 | 334,789 | 252,540 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 222 | 49 | -3,796 | 16,013 | 37,143 | 179,663 | 12,577 | 618 |
| Equity | 24,866 | 13,151 | 9,355 | 25,368 | 62,511 | 242,174 | 254,751 | 255,369 |
| Liabilities | 2,505 | 3,997 | 1,584 | 3,967 | 509,074 | 276,945 | 125,876 | 16,923 |
| Non-current assets | 140 | 1,065 | 1,964 | 20,285 | 435,467 | 474,073 | 338,141 | 167,376 |
| Current assets | 27,231 | 16,083 | 8,975 | 8,945 | 131,961 | 40,399 | 38,484 | 101,213 |
| Total assets | 27,371 | 17,148 | 10,939 | 29,230 | 567,428 | 514,472 | 376,625 | 268,589 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 51,176 | 98,120 | 42,958 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +79.3% | +61.3% | -27.2% | +115.5% | +162.2% | +232.1% | -31.2% | -24.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.8% | 0.3% | -34.7% | 54.8% | 6.5% | 34.9% | 3.3% | 0.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.9% | 0.4% | -40.6% | 63.1% | 59.4% | 74.2% | 4.9% | 0.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.0% | 0.1% | -14.6% | 28.6% | 25.3% | 36.9% | 3.8% | 0.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.3 | 0.2 | 0.2 | 8.1 | 1.1 | 0.5 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 22,105 | 35,658 | 25,950 | 55,918 | 146,612 | 417,273 | 334,789 | 252,540 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Pharmaservices - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-04-20 | 2026-04-27 | 235.20 |
| 2025-11-18 | 2025-11-23 | 194.44 |
| 2025-09-16 | 2025-09-17 | 194.24 |
| 2023-04-18 | 2023-04-24 | 126.35 |
| 2023-03-27 | 2023-03-28 | 3.12 |
| 2023-03-16 | 2023-03-26 | 170.19 |
| 2022-12-16 | 2022-12-28 | 308.23 |
| 2022-11-21 | 2022-12-15 | 152.96 |
| 2022-11-17 | 2022-11-18 | 152.96 |
Pharmaservices - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Pharmaservices, UAB (code 302627759) is a private limited liability company operating in rental and leasing of other heavy motor vehicles. In 2025, the company generated revenue of €252.5K and net profit of €618, which corresponds to a very thin profit margin of 0.2%. Revenue declined by 24.6% year on year and by 48.1% over two years, showing a steady downward trend from €486.8K in 2023 to €334.8K in 2024 and then to the 2025 level. Profitability weakened even faster: net profit fell from €179.7K in 2023 to €12.6K in 2024 and to a minimal level in 2025. The balance sheet remained conservatively financed, with total assets of €268.6K, equity of €255.4K and liabilities of €16.9K. Equity represented 95.1% of assets, and debt relative to equity was low at 0.07. Asset turnover stood at 0.94x, indicating that assets generated revenue broadly in line with their size. Revenue per employee was €252.5K, while profit per employee was €618.